Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board

Prof. Coyle to Provide Guidance on Company's Neuroscience Pipeline, with Emphasis on Schizophrenia LOS ANGELES, July 2, 2026 /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics that have the potential to restore synapses to improve...